CompletedPhase 2NCT04135417

Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis

Studying Complication in hemodialysis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Humacyte, Inc.
Principal Investigator
Shamik Shamik, MD, M.D
Humacyte, Inc.
Intervention
HAV(biological)
Enrollment
30 target
Eligibility
18 years · All sexes
Timeline
20192022

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04135417 on ClinicalTrials.gov

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

See all trials for Complication in hemodialysis

← Back to all trials